1-5 of 5
Francois Le Loarer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translational Aspects of Epithelioid Sarcoma: Current Consensus

Thomas G.P. Grünewald, Sophie Postel-Vinay, Robert T. Nakayama, Noah E. Berlow, Andrea Bolzicco, Vincenzo Cerullo, Josephine K. Dermawan, Anna Maria Frezza, Antoine Italiano, Jia Xiang Jin, Francois Le Loarer, Javier Martin-Broto, Andrew Pecora, Antonio Perez-Martinez, Yuen Bun Tam, Franck Tirode, Annalisa Trama, Sandro Pasquali, Mariagrazia Vescia, Lukas Wortmann, Michael Wortmann, Akihiko Yoshida, Kim Webb, Paul H. Huang, Charles Keller, Cristina R. Antonescu
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (6): 1079–1092.
https://doi.org/10.1158/1078-0432.CCR-23-2174
Published: 15 March 2024
View article titled, Translational Aspects of Epithelioid Sarcoma: Current Consensus
Open the PDF for Translational Aspects of Epithelioid Sarcoma: Current Consensus in another window
Journal Articles

Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis

Nicolas Penel, Sylvie Bonvalot, André-Michel Bimbai, Alexandra Meurgey, François Le Loarer, Sébastien Salas, Sophie Piperno-Neumann, Christine Chevreau, Pascaline Boudou-Rouquette, Pascale Dubray-Longeras, Jean-Emmanuel Kurtz, Cécile Guillemet, Emmanuelle Bompas, Antoine Italiano, Axel Le Cesne, Daniel Orbach, Julien Thery, Marie-Cécile Le Deley, Jean-Yves Blay, Olivier Mir
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18): 4105–4111.
https://doi.org/10.1158/1078-0432.CCR-21-4235
Published: 15 September 2022
View article titled, Lack of Prognostic Value of <em>CTNNB<sub>1</sub></em> Mutation Profile in Desmoid-Type Fibromatosis
Open the PDF for Lack of Prognostic Value of <em>CTNNB<sub>1</sub></em> Mutation Profile in Desmoid-Type Fibromatosis in another window
Includes: Supplementary data
Journal Articles

Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

Sophie Cousin, Coralie Cantarel, Jean-Philippe Guegan, Carlos Gomez-Roca, Jean-Philippe Metges, Antoine Adenis, Simon Pernot, Carine Bellera, Michèle Kind, Céline Auzanneau, François Le Loarer, Isabelle Soubeyran, Alban Bessede, Antoine Italiano
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8): 2139–2147.
https://doi.org/10.1158/1078-0432.CCR-20-3416
Published: 15 April 2021
View article titled, Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial
Open the PDF for Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial in another window
Includes: Supplementary data
Journal Articles

Correction: Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study

Maud Toulmonde, Jean-Yves Blay, Olivier Bouche, Olivier Mir, Nicolas Penel, Nicolas Isambert, Florence Duffaud, Emmanuelle Bompas, Thomas Esnaud, Romain Boidot, Damien Geneste, François Ghiringhelli, Carlo Lucchesi, Carine A. Bellera, François Le Loarer, Antoine Italiano
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4859.
https://doi.org/10.1158/1078-0432.CCR-19-1599
Published: 01 August 2019
View article titled, Correction: Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study
Open the PDF for Correction: Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study in another window
Journal Articles

Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study

Maud Toulmonde, Jean-Yves Blay, Olivier Bouche, Olivier Mir, Nicolas Penel, Nicolas Isambert, Florence Duffaud, Emmanuelle Bompas, Thomas Esnaud, Romain Boidot, Damien Geneste, François Ghiringhelli, Carlo Lucchesi, Carine A. Bellera, François Le Loarer, Antoine Italiano
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4611–4615.
https://doi.org/10.1158/1078-0432.CCR-18-3127
Published: 01 August 2019
View article titled, Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study
Open the PDF for Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study in another window
Includes: Supplementary data